Trial intelligence / Profile preview

Sustained Hypernatremia for Cerebral Edema in TBI

NCT01605357Phase 2Withdrawn

Sponsor
Massachusetts General Hospital
Start
Jul 2012
Primary completion
Jul 2013
Modality
Small Molecules, Device-based Delivery
01

Overview

A Phase 2 trial of hypertonic saline in traumatic brain injury (TBI), cerebral edema, sponsored by Massachusetts General Hospital. Planned start Jul 2012; status: withdrawn.

02

Drugs

hypertonic saline
03

Conditions

traumatic brain injury (TBI)cerebral edema

Beyond the preview

Go deeper on NCT01605357.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01605357.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call